See beyond sugar: uncovering risk in type 2 diabetes
15 Oct 2024
Clinical Theatre 1
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
This session’s objectives are:
- To understand how NICE T2DM guidelines have changed and why
- To know what it means to go beyond glucose management in people with T2DM and manage cardiovascular and renal risk
- To review what this means in practice and the benefits of implementing an action plan
AstraZeneca medicines will be mentioned during this presentation.
GB-58815, DOP: Sept 2024
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
.jpg/fit-in/1280x9999/filters:no_upscale()){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
)
){kind=logo}
){kind=logo}
